☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Type 2
Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA
March 16, 2021
Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Approval for Type 1 and Type 2 Diabetes
June 15, 2020
Load more...
Back to Home